**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Addison and Cushing International Federation
a/k/a: ACIF
Address:
P.O. Box 52137
The Hague, Intl 2505 CC
The Netherlands
Phone: 31--153-699339
Fax: 31--153-699339
800 Number: --
TDD: --
Email Address: info@nvacp.nl
The Addison and Cushing International Federation (ACIF), established in 1996, is a platform of organizations involved in the support of those affected with Addison's disease, Cushing's syndrome (or disease) and related adrenal or pituitary-related diseases (e.g., acromegaly, CAH and other disorders). ACIF maintains a listing of organizations, support groups and individuals who want to start support groups interested in the field of adrenal and pituitary disorders. The ACIF web site remains a part of the web site of the Dutch Addison and Cushing Society (NVACP). Whenever possible, messages will be diverted to existing patient support groups already known to ACIF. Addison's disease is a rare disorder characterized by deficiency of certain hormones (i.e., hydrocortisone and aldosterone) produced by the outer region (cortex) of the adrenal glands. Cushing's syndrome is a hormonal disorder characterized by abnormally increased levels of certain hormones (i.e., corticosteroid hormones) produced by the adrenal glands.
Chapters: 22
Website: http://www.nvacp.nl
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.